The neoplasms mortality rate in Japan is projected to increase steadily from 319.6 deaths per hundred thousand persons in 2024 to 328.4 by 2028. This represents a consistent year-on-year growth of around 0.7%. In 2023, the mortality rate was slightly lower, indicating a continuing upward trend in the forecasted years. The compound annual growth rate (CAGR) over this period shows a moderate rise in mortality rates linked to neoplasms.
Future trends to watch for include advancements in medical treatments and early detection methods, the progression of public health campaigns aimed at reducing cancer incidence, and the impact of an aging population, which could further influence these projected mortality rates.
